Clinical Trial Update: Novel Soluble Epoxide Hydrolase Inhibitor for Neuropathic Pain in Patients With Spinal Cord Injury [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for a novel soluble epoxide hydrolase inhibitor intended to treat neuropathic pain in patients with spinal cord injury; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain
• Spinal Cord Injury

Drugs mentioned

• Novel soluble epoxide hydrolase inhibitor

Snippet

Sponsor: EicOsis Human Health Inc. | Conditions: Spinal Cord Injuries, Neuropathic Pain | Phase 1 | Status: RECRUITING